{
"@context": "/terms/",
"@id": "/treatments/94a9736e-4e16-48d2-af84-992c08f14b35/",
"@type": [
"Treatment",
"Item"
],
"aliases": [
"pankbase-consortium:treatment_Telaprevir_1miG_ml"
],
"amount": 1,
"amount_units": "ng/mL",
"audit": {
"INTERNAL_ACTION": [
{
"category": "mismatched status",
"detail": "Released treatment [94a9736e-4e16-48d2-af84-992c08f14b35](/treatments/94a9736e-4e16-48d2-af84-992c08f14b35/) has deleted subobject award [U24DK13851](/awards/U24DK13851/).",
"level": 30,
"level_name": "INTERNAL_ACTION",
"name": "audit_item_status",
"path": "/treatments/94a9736e-4e16-48d2-af84-992c08f14b35/"
}
]
},
"award": {
"@id": "/awards/U24DK13851/",
"component": "data coordination"
},
"biosamples_treated": [],
"creation_timestamp": "2025-05-06T20:47:45.754569+00:00",
"depletion": false,
"description": "An oligopeptide consisting of N-(pyrazin-2-ylcarbonyl)cyclohexylalanyl, 3-methylvalyl, octahydrocyclopenta[c]pyrrole-1-carboxy, and 3-amino-N-cyclopropyl-2-oxohexanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection.",
"lab": {
"@id": "/labs/pankbase-consortium/",
"title": "Pankbase Consortium, PanKbase"
},
"purpose": "stimulation",
"release_timestamp": "2025-06-15T06:27:10.024313+00:00",
"schema_version": "7",
"status": "released",
"submitted_by": {
"@id": "/users/5e3038c4-baa5-4589-b3d8-ad2fe634e826/",
"title": "Ying Sun"
},
"submitter_comment": "https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:68595",
"summary": "Treatment of 1 ng/mL telaprevir",
"treatment_term_id": "CHEBI:68595",
"treatment_term_name": "telaprevir",
"treatment_type": "chemical",
"uuid": "94a9736e-4e16-48d2-af84-992c08f14b35"
}